Future Growth Opportunities in Generics: Impact of consolidation on market and competitive dynamics

The number of commercially lucrative drugs coming off patent has catalyzed the growth of the generics industry, creating significant profit opportunities for generics manufacturers. However, this market faces a considerable number of threats, with bulk manufacturers from developing countries becoming internationally competitive and the aggressive actions of branded pharmaceutical marketers in protecting their patent and market position resulting in ramifications for the sector as a whole. Future Growth Opportunities in Generics provides an in-depth analysis into the direction of the global generics market, evaluating competitive dynamics through a detailed review of major consolidation activity in the sector. Opportunities for future success are also explored, including the potential offered by biosimilars and the increasing focus by governments on healthcare cost containment, enabling you to determine the factors crucial to your success in the global generics market. more...

The CNS Market Outlook to 2011

Psychiatric and neurological disorders constitute as much as 35% of the disease burden in the seven major pharmaceutical markets, representing continuing opportunities for pharma companies in the CNS market. However, the increasing presence of generic products coupled with low levels of innovative launches has resulted in a slowdown in market growth and considerable unmet need across the spectrum of CNS disorders. more...

The Cancer Market Outlook to 2011

Innovation is the key driving force in the cancer market, creating strong opportunities for biotech and pharma companies to launch new products and benefit from high volume sales and a strong competitive position. 'The Cancer Market Outlook to 2011' provides detailed analysis on 9 indications in the cancer market, identifying growth brands, key drug classes and leading companies. The 6-year epidemiology and product sales forecasts detailed in this report will enable you to evaluate the changes in the competitive positions of leading companies in the cancer market and ensure your R&D pipeline is aligned with future market opportunity to sustain revenue growth. Use this report to benchmark the strategies behind the market-leading products of today and identify which products will be best positioned for growth over the period 2006-2011. more...

Next-Generation Nutraceuticals: Food and pharma convergence

Next-Generation Nutraceuticals is a new report published by Business Insights that provides analysis of how the food and pharmaceutical industries are becoming more aligned in their approach to consumer health. This report assesses the changing regulatory landscape in addition to how the strategies of leading ingredients, food, drinks and pharmaceutical companies are evolving in the new consumer health marketplace. Understand how food and drinks manufacturers are applying genomic and proteomic technologies that are widely used in the pharmaceutical industry in order to create increasingly sophisticated functional food products with this new report. more...

Innovation in Drug Delivery: The future of nanotechnology and non-invasive protein delivery

Innovation in Drug Delivery provides an in-depth examination of product launches and pipeline drugs with novel drug delivery mechanisms set to revolutionize the market, such as products using ALZA Corporation's E-TRANS and Altea's PassPort patch transdermal technologies. This report will enable you to evaluate key marketed drugs, including Emend and Megace, and gain an insight into novel pipeline products to anticipate upcoming product launches and position yourself for success.Use this report to understand how nanotechnology and other key technologies are changing drug delivery and how these can be implemented into your R&D process. Assess the impact of innovation in therapy areas including oncology, diabetes and infectious diseases and identify future opportunities for market growth. more...